Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heterogeneous nuclear ribonucleoprotein A1 pseudogene 42 (HNRNPA1P42)
- Target
- HNRNPA1P42
- Molecular classification
- Other (pseudogene; not an active protein, enzyme, or receptor)
01
Overview
Heterogeneous nuclear ribonucleoprotein A1 pseudogene 42 (HNRNPA1P42) is a human pseudogene located in the genome related by sequence homology to the functional RNA-binding protein HNRNPA1. Unlike protein-coding genes, pseudogenes such as HNRNPA1P42 do not encode a functional protein and are not considered therapeutic targets. Some pseudogenes may have regulatory or non-coding RNA roles, but there is no published evidence supporting a biological or pathological role for HNRNPA1P42. The functional gene HNRNPA1, however, is a major regulator of pre-mRNA processing, alternative splicing, and is implicated in various diseases, especially cancers; these functions are not attributed to HNRNPA1P42. Summary of main issues: - HNRNPA1P42 is *not* a therapeutic target. - It is a **pseudogene** only, with no protein product or established biological function. - If you seek information on a therapeutically actionable target, refer to **heterogeneous nuclear ribonucleoprotein A1 (HNRNPA1)**, not the pseudogene.
- Other names
- HNRNPA1P42Heterogeneous nuclear ribonucleoprotein A1 pseudogene 42
02
Mechanism of action
None. No drugs act on this pseudogene.
03
Biological functions
None relevant, as pseudogenes do not encode functional proteins. They may have regulatory roles at the RNA level in rare cases, but there is no evidence for this for HNRNPA1P42.
04
Disease associations
None established, as HNRNPA1P42 does not produce a protein or fulfill an active cellular function. Functional HNRNPA1 (the parent gene) is implicated in cancer, alternative splicing, and other processes, but not the pseudogene HNRNPA1P42.
05
Safety considerations
None relevant; pseudogenes do not have therapeutic targeting concerns.
06
Interacting drugs
None. No known drugs interact with a pseudogene; drug interactions pertain to the active protein HNRNPA1, not HNRNPA1P42.
07
Biomarkers
None. No reputable sources cite HNRNPA1P42 as a biomarker.
Beyond the preview
Go deeper on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 42 (HNRNPA1P42).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 42 (HNRNPA1P42).